Erik Schaefer
Company: AssayQuant Technologies Inc.
Job title: CEO
Seminars:
Monitoring Continuous Enzyme Activity with Fluorogenic Sensor Assays Enables Data-Rich Decisions for Improved Kinase & Phosphatase Drug Discovery 2:15 pm
Advantages of PhosphoSens® technology as a continuous activity assay (a progress curve in every well) Kinome selectivity profiling at low or high ATP with insight into compound dependent kinetics and MOA Deep characterization of kinase inhibitor potency for reversible or irreversible inhibitorsRead more
day: Day One